GLP-1 agonists, phentermine-topiramate, or other FDA-approved agents based on individual patient factors
Liposomal glutathione does not directly lead to weight loss but it supports several things that may lead to weight loss
Adipex-P, DailyMed (2024) Phentermine hydrochloride, PDR Ozempic, DailyMed (2023) Semaglutide, PDR Rybelsus, DailyMed (2024) Wegoby, DailyMed (2024) A review of current guidelines for the treatment of obesity, American Journal of Managed Care (2022) Pharmacologic treatment of overweight and obesity in adults
Triptans (sumatriptan, rizatriptan, eletriptan, zolmitriptan, and others) have no documented pharmacokinetic interaction with GLP-1 medications
Before we dive into each formulation, here is a quick reference: The pattern is simple